Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus

J Diabetes Res. 2013:2013:184258. doi: 10.1155/2013/184258. Epub 2013 May 23.

Abstract

Diabetes mellitus (DM) is a pandemics that affects more than 170 million people worldwide, associated with increased mortality and morbidity due to coronary artery disease (CAD). In type 1 (T1) DM, the main pathogenic mechanism seems to be the destruction of pancreatic β -cells mediated by autoreactive T-cells resulting in chronic insulitis, while in type 2 (T2) DM primary insulin resistance, rather than defective insulin production due to β -cell destruction, seems to be the triggering alteration. In our study, we investigated the role of systemic inflammation and T-cell subsets in T1- and T2DM and the possible mechanisms underlying the increased cardiovascular risk associated with these diseases.

MeSH terms

  • Adaptive Immunity / immunology*
  • Adult
  • Aged
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / immunology*
  • Cardiovascular Diseases / pathology
  • Cell Line
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / immunology*
  • Diabetes Mellitus, Type 1 / pathology
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / immunology*
  • Diabetes Mellitus, Type 2 / pathology
  • Female
  • Humans
  • Inflammation / complications
  • Inflammation / immunology*
  • Inflammation / pathology
  • Insulin Resistance / immunology
  • Insulin-Secreting Cells / immunology
  • Insulin-Secreting Cells / pathology
  • Male
  • Middle Aged
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / pathology